Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-15-074175

Options or other derivatives

  • VP, Research acquired 34,337 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
McKew John C. VP, Research 2015-10-01 Grant or award · Employee Stock Option (right to buy) +23,000 23,000 D
McKew John C. VP, Research 2015-10-01 Grant or award · Employee Stock Option (right to buy) +11,337 11,337 D
Loading xslF345X03/doc4.xml…